Log In
Print this Print this

REC 1819

  Manage Alerts
Collapse Summary General Information
Company Recordati S.p.A.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB) and incontinence
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today